High-dose oral B12 (10002000 micrograms daily) may be effective even in some malabsorption conditions through passive diffusion
But I think theyre just saying the same thing
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
Methylcobalamin and adenosylcobalamin both occur naturally in food and work together in our bodies to provide adequate vitamin B12 intake for bodily function
By modulating NNMT activity, this compound has been studied in research contexts for its effects on metabolic pathways and cellular NAD+ availability
Long-term use of inhaled corticosteroids, especially at high doses, may contribute to decreased bone mineral density, increasing the risk of osteoporosis and fractures
